Delivery Order SPE2DB24D2100-SPE2DB25FBFYE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ramelteon 8 mg tablets in unit-dose packaging (50-count) valued at $2,315.08. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $6,147.26 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (50-unit dose packaging) on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ramelteon 8 mg tablets (100-count units) with a contract ceiling value of $3,606.44. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The ultimate completion date is August 14, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,095.54 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (30-count supply) on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ramelteon is a prescription sleep aid medication used in the treatment of insomnia, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (100-count) with a contract value of $2,035.44. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award involves no set-aside designation, reflecting the contractor's...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,177,965 units of the sleep medication Ramelteon 8 mg Tablet 30s. The $1,415.04 contract has a performance period through May 8, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifteen thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of thirty boxes of eight milligram ramelteon tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from September 6 to September 7, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50 tablets) with a ceiling value of $17,821.74. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, performing out of the contractor's corporate office in Conshohocken, Pennsylvania, and is scheduled for completion by August 21, 2025. Ramelteon is a melatonin...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,511.45 contract is for the provision of 30-count tablets of the pharmaceutical drug Ramelteon 8 mg. The delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is a leading global pharmaceutical sourcing and distribution services company that has received numerous federal contract awards from DLA...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,122 to Amerisourcebergen Drug Corporation. The order is for 30 packages of 8mg Ramelteon tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 7, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform as the prime contractor under this order placed against an existing DLA contract vehicle. No set aside designation or...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFYEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,039.56 to AmerisourceBergen Drug Corp for 30 tablets of Ramelteon 8 mg, a medication used to treat insomnia. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's role as a critical federal medical vendor reflects its demonstrated capability to fulfill federal procurement requirements across diverse pharmaceutical product categories through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/20/25 |